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Assessing procedural pain in infants: a feasibility study
evaluating a point-of-care mobile solution based on
automated facial analysis
Kreshnik Hoti, Paola Teresa Chivers, Jeffery David Hughes

Summary

Background The management of procedural pain in infants is suboptimal, in part, compounded by the scarcity of a
simple, accurate, and reliable method of assessing such pain. In this study, we aimed to evaluate the psychometric
properties of the PainChek Infant, a point-of-care mobile application that uses automated facial evaluation and
analysis in the assessment of procedural pain in infants.
Methods Video recordings of 40 infants were randomly chosen from a purposely assembled digital library of
410 children undergoing immunisation as part of their standard care in Prishtina, Kosovo, between April 4, 2017,
and July 11, 2018. For each infant recording, four 10 s video segments were extracted, corresponding to baseline,
vaccine preparation, during vaccination, and recovery. Four trained assessors did pain assessments on the video
segments of 30 infants, using PainChek Infant standard, PainChek Infant adaptive, the Neonatal Facial Coding
System-Revised (NFCS-R) single, the NFCS-R multiple, and the Observer administered Visual Analogue Scale
(ObsVAS), on two separate occasions. PainChek Infant’s performance was compared to NFCS-R and ObsVAS using
correlation in changes in pain scores, intra-rater and inter-rater reliability, and internal consistency.
Findings 4303 pain assessments were completed in two separate testing sessions, on Aug 31, and Oct 19, 2020. The
study involved videos of 40 infants aged 2·2–6·9 months (median age 3·4 months [IQR 2·3–4·5]). All pain assessment
tools showed significant changes in the recorded pain scores across the four video segments (p≤0·0006). All tools
were found to be responsive to procedure-induced pain, with the degree of change in pain scores not influenced by
pre-vaccination pain levels. PainChek Infant pain scores showed good correlation with NFCS-R and ObsVAS scores
(r=0·82–0·88; p<0·0001). PainChek Infant also showed good to excellent inter-rater reliability (ICC=0·81–0·97,
p<0·001) and high levels of internal consistency (α=0·82–0·97).
Interpretation PainChek Infant’s use of automated facial expression analysis could offer a valid and reliable means of
assessing and monitoring procedural pain in infants. Its clinical utility in clinical practice requires further research.
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Introduction
Procedural pain is acute pain associated with
investigations, treatments, or procedures done in the
course of delivering health care.1,2 As such, pain can arise
from any procedure causing actual or potential tissue
damage.1 Such interventions include simple procedures
such as intravenous cannulation, venepuncture, finger
and heel pricks, immunisations, and dressing changes,
to more invasive procedures such as lumbar punctures
or bone marrow biopsies.1,2 Procedures occur in a variety
of settings, from hospitals or day surgery centres to
ambulatory care clinics, general practice, dental clinics,
and the home care environment.1
Although procedural pain might be associated with an
isolated event, it is not uncommon for children to have
multiple painful procedures daily when being cared for
in hospital or ambulatory settings.3 Within emergency
departments, procedures represent one of the most
common sources of acute painful stimulus in children,
www.thelancet.com/digital-health Vol 3 October 2021

with studies showing up to 80% of children undergoing
painful diagnostic procedures.4 Unfortunately, there
are numerous studies reporting that pain, especially
procedural pain, in children including infants, is often
poorly managed.3,5 These findings are despite the
optimisation of the management of paediatric pain being
a key health-care priority of WHO and leading paediatric
and pain societies.3
Poorly managed procedural pain can have short-term
and long-term consequences.1,5 Repeated procedures
warrant careful pain management as insufficient pain
relief could lead to anxiety and distress during
subsequent episodes.3,5,6 In infants, a major challenge to
managing pain is the ability to assess it accurately and
reliably. The generally accepted standard for pain
assessment is self-report; however, in preverbal children
who cannot communicate their pain, age-appropriate
behavioural or observational pain assessment tools are
recommended.6
e623
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Research in context
Evidence before this study
In this study, we aimed to validate a novel pain assessment tool
for infants, PainChek Infant. Initially, we reviewed currently
available evidence on pain assessment tools in infants. In doing
so, we searched the following databases: MEDLINE, Embase,
PsycInfo, and Joanna Briggs Institute Database from inception
through to Oct 31, 2020, using keywords agreed between three
reviewers ([“infant”, “pain measurement”, “pain assessment”,
“pain scale”, or “rating pain”], with [“review”, “systematic
review”, or “meta-analysis”]). We also individually searched
leading paediatric journals. Our key criteria for literature
selection related to identifying and reviewing currently
available systematic reviews that reported pain assessment in
infants, and were available in English. PRISMA protocol was
consulted in reviewing the relevant literature. Following the
literature search, we selected the records which fulfilled our
criteria and conducted a qualitative analysis of the full papers.
We concluded that there are over 40 pain assessment tools that
have been developed thus far that are based around observer
identification and evaluation of specific biomarkers indicative
of pain. However, to our knowledge there is no automated pain
assessment tool used in infants. All currently available tools rely
on users making their decisions based on subjective
observations of the child. Furthermore, our review of the
literature showed that the presence of so many pain
assessment tools for infants is marred by an absence of
universal standardisation, which has resulted in a variety of
criteria being used by clinicians in order to assess pain in
infants. In practice, this could result in variation in
interpretations of the presence and intensity of pain,
which could go on to have an effect on how pain is treated.
Added value of this study
This study describes the evaluation of the psychometric
properties of a technology-based solution for the assessment of

Common to the multitude of existing observational
pain assessment tools is the evaluation of the child’s facial
expression.7 However, as a result of practical difficulties
with manual decoding of facial expressions, automated
facial expression analysis is a topic of broad research.8 In
children, there have been a number of studies exploring
automated pain facial expression recognition.8,9 However,
we are not aware of any automated pain assessment tools
for infants that have been tested against existing paperbased validated tools and that are available for use at
point-of-care in a mobile application (app).
The aim of this study was to evaluate the psychometric
properties of the PainChek Infant, a point of care app
that utilises automated facial expression analysis to
detect pain in infants aged 1–12 months, against two
scales: the Neonatal Facial Coding System (NFCS),10–14
which has been designed for procedural pain assessment,
and the Observer administered Visual Analogue Scale
e624

procedural pain in infants. PainChek Infant uses automated
facial evaluation and analysis to detect six facial action units
(AUs) indicative of the presence of pain. In this study,
we showed that, when compared to manual assessment using
either the Neonatal Facial Coding System-Revised (a validated
facial action recognition tool based observational pain
assessment) or an observer administered Visual Analogue Scale,
PainChek Infant showed moderate to excellent validity,
inter-rater and intra-rater reliability, and internal consistency.
Further, in accordance with previous research, the AUs detected
represent pain intensity and pain-related distress. Using
automated facial evaluation and analysis PainChek Infant
provides a rapid (assessments take 3 s), valid, and reliable
means of assessing procedural pain.
Implications of all the available evidence
Although there are currently many available tools to assess
procedural pain in infants, they are often underused and, as a
result, infants continue to undergo painful procedures without
adequate pain management, resulting in short-term and longterm negative outcomes. Artificial intelligence in this field can be
used to support clinician decision making, allow curiosity-driven
care, remove the need to complete mundane tasks, improve
communication, and facilitate collaboration. Evaluation of the
face is central to all observational pain assessment tools, as the
face is highly accessible and facial expressions are considered the
most encodable feature of pain. However, decoding of the face by
clinicians and parents alike is difficult when trying to discern pain
from other causes of distress. It is therefore important that new
tools developed to assess pain in this vulnerable population take
advantage of technology to objectify and simplify the process,
thus allowing users to better identify and quantify pain. This
study adds to the body of evidence to support the use of artificial
intelligence in the assessment of pain in the infant population,
and its advantages over humans in decoding pain behaviours.

(ObsVAS) pain scale, which is used to quantify procedural
pain intensity. In doing so, we question whether it is
feasible to use the automated facial expression analysis
of PainChek Infant to detect and quantify pain.

Methods

Study design and population
In this feasibility study, we evaluated the PainChek Infant
against the Neonatal Facial Coding System-Revised
(NFCS-R) and the ObsVAS to investigate whether
PainChek’s automated facial expression analysis on a
series of videos of infants undergoing immunisation can
accurately detect and quantify pain. The infant videos
used in this study came from a purposely assembled
digital library of children undergoing routine immu
nisation at an immunisation clinic in Prishtina, Kosovo.
The parents or guardians of the children provided
informed written consent for their child’s immunisation
www.thelancet.com/digital-health Vol 3 October 2021
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to be video recorded and used for research and
development purposes. The digital library consisted of
410 children aged 0–12 years, of whom 329 were infants.
After reviewing these infant videos for suitability, on the
basis of the infant’s face not being obstructed from view,
we randomly chose 40 of them, using an electronic
randomiser. In cases when there was a substantial
obstruction, the next video in line was chosen. Each
infant was recorded for approximately 60 s before and
90 s after the vaccination. This study was approved by
human research ethics committees of the Faculty of
Medicine, University of Prishtina, Kosovo (approval
number: 3812/17) and Curtin University, Perth, WA,
Australia (approval number: HRE2020-0315).

Procedures
PainChek Infant uses artificial intelligence (AI) for the
automated recognition and analysis of an infant’s face,
allowing detection of six facial action units (AUs)
indicative of the presence of pain: AU4 (brow lowering),
AU9 (wrinkling of nose), AU15 (lip corner depressor),
AU20 (horizontal mouth stretch), AU25 (parting lips),
and AU43 (eye closure). These facial actions represent
specific muscle movements (contractions or relaxations)
as classified by the Baby Facial Action Coding System.13
Each of the six AUs is scored using a binary scale
(0=absent, 1=present), yielding a total potential score
of 6. The tool has been specifically designed to assess
pain in infants (aged 1–12 months), taking into account
the facial actions commonly associated with pain in
this population. The algorithms created during the
PainChek Infant development were trained on images
corresponding to this age group. The algorithms for
the app were developed by data scientists from the
Universida de Castilla-La Mancha, Spain, using a nonproprietary database of videos of infants undergoing
routine immunisations. A five-fold cross validation
methodology was used, using independent training
and validation datasets. The automated facial analysis
could be completed either using a fixed video duration
(standard 3 s video mode) or using a fixed number of
minimum valid images (video adaptive mode). The
video adaptive mode has been developed to address the
potential for increased head movements that often
accompany pain or distress in infants.
The NFCS-R, one of the two PainChek Infant com
parators in this study, utilises the same construct as
PainChek Infant in that it uses facial actions as indicators
of pain, but is assessor-rated rather than automated. The
original NFCS contained ten facial actions; however, a
1996 study showed that reducing the detection of facial
actions to five improved the specificity for pain assessment,
while maintaining sensitivity and validity.15 The NFCS-R
contains the following five facial actions:14 brow bulge, eye
squeeze, nasolabial furrow, horizontal mouth stretch, and
taut tongue. The scoring system in the NFCS-R is also
binary, with final pain score between 0 and 5 depending
www.thelancet.com/digital-health Vol 3 October 2021

on the presence of each of the above facial actions. The
NFCS has been used and evaluated in procedural pain16
and postoperative pain15 in infants and it can evaluate the
effect of treatment, as well as discriminate between tissue
insult and non-tissue insult procedures.13,15,16 Overall,
the NFCS has been shown to have good inter-rater
reliability,14,17–19 construct validity,13,15,16 and convergent
validity.18,19 More details on the characteristics of the
NFCS-R have been published elsewhere.14
The ObsVAS, the second PainChek Infant comparator,
is a commonly used tool that measures and quantifies
pain and distress.20 The scale consists of a 100 mm line
on which 0 mm represents no pain or distress and
100 mm represents the worst possible pain or distress.
The level of pain or distress is determined by the distance
from the 0 mm point. The ObsVAS scale was included to
gain an estimate of the level of pain or distress that
assessors perceived the infant to be experiencing during
the phases of the procedure. A 2009 study reported
ObsVAS to have good-to-excellent intra-rater reliability
(intraclass correlation coefficient [ICC] 0·69 to 0·91) and
inter-rater reliability (ICC 0·55 to 0·97), and strong
criterion validity compared with the Modified Behavioural
Pain Scale (Pearson’s rho 0·81–0·94) in infants under
going vaccination.20
The video recordings for each of the 40 infants were
divided into segments to show different phases of the
procedure: baseline (before any attempt to prepare the
infant for the procedure was made [ie, while still in their
parent’s arms]), preparation (while the infant’s arm was
prepared and swabbed), during vaccination (the painful
part of the procedure [ie, the 10 s after needle insertion]),
recovery (after the painful procedure [ie, between 10 s
and 40 s after the needle insertion). It was presumed that
any behavioural change suggestive of distress in the
infant in baseline and preparation segments was most
likely non-pain related, as these infants were yet to have
their injection. 160 video segments were prepared for
review. Each video segment was 10 s in length (the first
10 s segment without substantial obstruction was chosen)
as required for NFCS-R video analysis.12
Four assessors used the three pain assessment
instruments to assess the pain or distress experienced by
the infant. Assessors were blinded to each other’s results
and did their assessments and data entry remotely via
a purposefully designed electronic data management
system (EDMS, version 1). The assessors accessed the
EDMS with their unique study identification number to
ensure that they only assessed the infants allocated to
them. Every assessor was assigned 120 video segments on
which to do the pain assessments, from one of two testing
session sets. Each video testing set included 30 infants,
chosen from the pool of 40 infants, ten of whom were
unique to that testing session set. This assignment
method ensured independent, paired pain assessments
were completed by at least two assessors on each video
segment. Each testing session dataset was assigned to

For more on the electronic
randomiser see www.
randomizer.org
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See Online for appendix

one clinically experienced assessor (ie, paediatric nurses)
and one clinically naive assessor (ie, nursing students
who have not yet started their paediatric placements).
To minimise recall bias, each assessor completed two
separate testing sessions 4 weeks apart. PainChek Infant
facial assessments were completed using version 1.3
(V17) installed onto an iPad Mini-4 (Cupertino, CA, USA,
IOS version 13.6.1). The NFCS-R was incorporated into
the EDMS so that facial actions observed could be entered
whilst the assessors watched the video segments, and a
slider bar was incorporated into the EDMS so that the
assessor could directly enter their ObsVAS scores. Results
obtained from the three pain assessment scales were
entered into the EDMS. In case of PainChek Infant, after
recording the data, the assessment was cancelled in
the app so that the results were not retained on the device.
During the first testing session, the video segments,
without audio, were loaded into the EDMS for the assessor
to view and record their results. Assessors were required
to complete their pain assessments using the tools in
this order: NFCS-R single video viewing (NFCS-R single),
NFCS-R multiple video viewing (NFCS-R multiple),
ObsVAS, PainChek Infant video adaptive mode (PainChek
Infant adaptive), and PainChek Infant standard 3 s video
mode (PainChek Infant standard). This order was chosen
to minimise bias that could occur by using automatic
PainChek Infant before other tools that require assessor
rating. However, the order in which the 30 subjects
appeared in both testing session sets was randomly
allocated by the research team. All four video segments of
each of the 30 infants was assessed using the same tool,
and once the assessment of all four video segments was
completed for an individual infant and submitted into the
EDMS, they could no longer be viewed by the assessor.
This approach was adopted to reduce recall bias. After
completing assessments of all the videos in their testing
session set using one tool, the assessors repeated the
assessments using the next allocated tool. To further avoid
recall bias, the order in which video segments were
presented for assessment was automatically and randomly
assigned by the EDMS for each pain assessment method.
In the second testing session, 4 weeks later, each assessor
completed assessments for the same video segments as
they had done in the first testing session, without access to
their previous results. In the second testing session,
assessors did not repeat the PainChek Infant assessments,
rather these assessments were completed independently
through a PainChek Infant simulator.
To ensure competency in the use of the pain assessment
tools, assessors were required to complete training in the
use of PainChek Infant, the NFCS-R,12 and ObsVAS
before data collection began. The assessors were also
familiarised with the use of the EDMS.

Statistical analysis
The sample size was based on a minimum of five patients
needed to evaluate every item included in the tool.21 As the
e626

PainChek Infant facial domain has six items, a minimum
sample size of 30 was necessary. For practical reasons, a
sample of 40 was chosen to allow instances in which
matched pain assessments could not be completed (eg, if
the automated facial analysis failed after two attempts).
IBM SPSS Statistics version 26 was used for the
data analysis, unless otherwise stated, with statistical
significance set at p<0·05, two-tailed. PainChek Infant
results were described using frequency and percentage.
A binomial logit link generalised linear mixed model
(GLMM) assessed each facial action (dependent outcome)
with video segments (baseline, preparation, during,
recovery), assessors (fixed factor), and infants treated as a
random factor (see appendix p 1 for model specifications).
Pain and distress scores were not normally distributed,
as assessed by a Kolmogorov-Smirnov normality test.
Pain and distress scores were described using mean, SD,
median, and IQR for all assessment methods and video
segments. A gamma distribution with log link generalised
estimating equation (GEE) model was used to examine
any differences in pain scores across video repeats,
controlling for repeated infant, video segment, assessor,
and repeat occasion (see appendix p 1). For all GEE
models, test of model effects (Wald [χ²]), parameter
estimates, and Bonferroni corrected pairwise comparisons
were reported.
A change score was calculated to assess the respon
siveness of the scales to change. The painful procedure
change score was calculated for each method by
computing the pain score during vaccination minus the
baseline score. The non-painful procedure change score
was calculated for each method by computing the pain
score at preparation minus the baseline score. Painful and
non-painful change scores were described using mean,
SD, 95% bias corrected and accelerated (BCa) confidence
intervals (CI). BCa CI were computed using 1000 samples
with sampling stratified on assessors. We considered
responsiveness shown if the change in scores was more
than 2 points for PainChek Infant methods, or more than
33% for alternative methods, and the rationale for these
boundaries is given in the appendix (p 1). A change in
scores should not be seen for non-painful procedures.
For each method, a linear mixed model (LMM) was used
to examine the relationship of change in pain scores
for painful and non-painful procedures. The LMMs
examined pain score as a continuous outcome, with
procedure (painful/non-painful) and assessors treated as
fixed factors, and infants treated as a random factor
(appendix p 1).
Responsiveness of the scale for pain was also evaluated
by grouping infants by score at baseline or preparation
phase using the PainChek Infant method into those with
low pain scores (<3) and those with high pain scores (≥3).
The grouping of infants into low and high pain scores
using the ObsVAS and percentage NFCS-R and NFCS
(mean score [ie, sum of items observed divided by sum of
items visible] multiplied by 100) used a cut-point score of
www.thelancet.com/digital-health Vol 3 October 2021
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compared Z scores of ObsVAS, NCFS-R multiple, and
NCFS-R single viewing with PainChek Infant adaptive
and PainChek Infant standard.
Pain score inter-rater differences were examined
with ICC with 95% CI separately for testing session,
method, and video segment. ICC investigations were also
done separately for assessor type. ICC values were
interpreted as poor (<0·50), moderate (≥0·50–0·75), good
(>0·75–0·90), and excellent (>0·90).24 Cronbach alpha was
used to assess the internal consistency between the four
assessors for each method with α greater than 0·70
considered acceptable. Pain scores (ObsVAS, NCFS-R
multiple, and NCFS-R single) for the first and second
testing sessions were combined (matching infant video,
segment, method, and assessor) to examine intra-rater
differences. Mean pain scores for PainChek Infant video
adaptive mode, PainChek Infant standard 3 s video mode,
and PainChek Infant standard 3 s video mode simulated

50% or higher for the high pain score category and
scores below 50% for the low pain score category. A LMM
with pooled session data examined responsiveness using
pain score as a continuous outcome, with fixed effects
pain (high or low pain during baseline or preparation),
procedure (painful or non-painful), session (first or
second), assessment method, assessors, and infants
treated as a random factor.
A repeated measures correlation was done to examine
whether the scales were measuring the same construct,
using the rmcorr function in RStudio version 1.3.1093
with 1000 repetition bootstrap 95% CIs reported. We
considered scales with r>0·75 as measuring the same
construct. Repeated measures Bland-Altman plots22 were
used to assess the level of agreement between methods,
using MedCalc software, version 19.5.3. This procedure
is based on the calculations described by Zou.23 We
calculated Z scores from the first testing session, and
First testing session

Second testing session

Baseline

Preparation

During

Recovery

Baseline

Preparation

During

Recovery

118

118

118

118

120

119

120

120

ObsVAS
n
Mean

1·9%

8·0%

83·0%

23·1%

2·9%

6·8%

81·2%

24·6%

SD

5·5%

17·7%

26·4%

27·8%

8·8%

15·7%

27·9%

27·8%

Median

0%

0%

95%

14·5%

0%

0%

95%

15%

IQR

0–0%

0–10%

80–100%

0–0%

0–10%

70–100%

0–40%

0–40%

NFCS-R multiple*
n
Mean

119

119

119

119

120

120

120

119

7·9%

17·4%

91·2%

40·9%

9·7%

15·6%

92·0%

42·2%

15·5%

28·0%

22·5%

41·0%

17·6%

26·5%

20·5%

41·3%

Median

0%

0%

100%

0%

0%

100%

IQR

0–0%

0–25%

100–100%

0–20%

0–20%

100–100%

SD

25%
0–80%

25%
0–80%

NFCS-R single*
n
Mean
SD

120

120

120

120

120

120

120

119

8·5%

15·0%

90·0%

40·3%

8·5%

14·2%

89·3%

39·5%

16·4%

27·4%

25·1%

40·8%

14·4%

26·2%

25·0%

40·2%

0%

0%

100%

0–20%

0–20%

100–100%

Median

0%

0%

100%

IQR

0–20%

0–20%

100–100%

25%
0–80%

20%
0–80%

PainChek Infant adaptive†
n

NA

NA

NA

NA

Mean

115
10·0%

116
10·0%

114
83·3%

25·0%

NA

NA

NA

NA

SD

13·3%

15·0%

28·3%

30·0%

NA

NA

NA

NA

Median

0%

0%

17%

NA

NA

NA

NA

IQR

0–1%

0–1%

NA

NA

NA

NA
35%

100%
4–6%

114

0–2%

PainChek Infant standard†
n

37

36

36

Mean

113
10·0%

115
11·7%

115
85·0%

25·0%

10·0%

11·7%

86·7%

28·3%

SD

15·0%

18·3%

28·3%

31·7%

15·0%

20·0%

26·7%

33·3%

Median

0%

0%

0%

0%

IQR

0–1%

0–1%

0–1%

0–1%

100%
5–6%

113

17%
0–2%

100%
5–6%

17%
0–3%

n=number of assessments. *Scores ranged from 0 to 5 and are presented here as percentage of maximum score. Scores were calculated using only valid datapoints
(ie, missing datapoints were ignored); however, if all facial features were not visible then the pain score was considered missing. †Scores ranged from 0 to 6 and are presented
here as percentage of maximum score, and were simulated during the second testing session.

Table 1: Description of pain and distress scores for each video segment, by assessment method, for the first and second testing sessions

www.thelancet.com/digital-health Vol 3 October 2021
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A

100

Mean pain score (%)

80

were combined (matching infant video, segment, and
method) to examine intra-rater differences. All models
used two-way mixed effects with absolute agreement.

Session 1
PainChek Infant adaptive
PainChek Infant standard
NFCS-R single
NFCS-R multiple
ObsVAS

Role of the funding source
The funder of the study is a previous or current employer
of authors KH, JDH, and PTC who have had a role in
the study design, data collection, data analysis, data
interpretation, and writing of the report.

60

Results

40

Using 40 individual videos of White infants undergoing
immunisation, 4303 pain assessments were completed in
two separate sessions, starting on Aug 31, and Oct 19, 2020.
Infants were aged 2·2 to 6·9 months, with a mean age of
3·6 months (SD 1·3) and a median age of 3·4 months
(IQR 2·3–4·5). 24 (60%) of 40 infants were female.
2384 assessments were conducted using the five pain
assessment methods during the first testing session,
including 119 using NFCS-R multiple, 120 using NFCS-R
single, 120 using PainChek Infant adaptive, 119 using
PainChek Infant Standard, and 118 using ObsVAS. All
assessors completed 30 assessments per video segment
using each assessment method, apart from one assessor
who only completed 29 assessments using NFCS-R
multiple, 29 assessments using PainChek Infant Standard,
and 28 assessments using ObsVAS Pain scores because
this assessor failed to save the completed assessments in
the EDMS before moving to the next set of video segments.
During the second testing session, 1439 assessments were
done using three methods (table 1), and an additional
160 assessments were done by simulation (ie, no assessor)
independently from the main study using the PainChek
Infant standard simulator.
The presence of facial action peaked during vaccination,
and were slightly higher at recovery compared with
baseline levels, according to PainChek Infant adaptive and
PainChek Infant standard (first testing session), and
PainChek Infant standard simulated (second testing
session; figure 1; appendix p 2). The GLMM indicated
that there was a significant difference between video
segments for the presence of each of the facial actions
(p<0·001; appendix p 2). In the first testing session, across
all assessments using PainChek Infant adaptive and
PainChek Infant standard, there were 41 (4%) failures
out of a total of 956 recorded assessments (including
21 [4%] failures of 480 assessments using PainChek
Infant adaptive and 20 [4%] failures of 476 assessments

20
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NFCS-R single
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PainChek Infant standard simulation

Mean pain score (%)
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Figure 1: Pain score changes for each video segment by assessment method,
during the first testing session (A), second testing session (B), and combined
testing session scores (C)
PainChek Infant adaptive and PainChek Infant standard (scored on a scale of 0–6)
and NFCS-R single and NFCS-R multiple (scored on a scale of scale 0–5) are
presented here as percentages. The error bars represent 95% CIs.
NFCS-R=Neonatal Facial Coding System-Revised. ObsVAS=Observer administered
Visual Analogue Scale.
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using PainChek Infant standard). Reported failures
commonly related to poor video quality, posture of the
child, or obstruction of the child by the nurse or parent.
Excessive head movement contributed to failure in only
five occasions. PainChek Infant standard simulated
recorded 17 (11%) failures out of 160 segment assessments
attempted. These failures were due to the automatic start
of the assessment by the system, which meant that the
assessor was not able to effectively judge the most suitable
time to start the assessment. For failures, only the single
segment datapoint was treated as missing, with remaining
segment datapoints retained in the analysis. The GEE
analysis reported a significant difference between video
segments for the presence of facial action frequencies for
NFCS-R single and NFCS-R multiple (appendix p 3).
The pain scores for each assessment method at each
video segment are described in table 1 for both testing
session one and session two. GEE models controlling for
assessor and video segment did not detect a significant
difference in pain scores across the two testing sessions,
using either NFCS-R single (Wald χ²=0·1; p=0·75),
NFCS-R multiple (Wald χ²=0·1; p=0·78), or ObsVAS
(Wald χ²=0·8; p=0·39). When the PainChek Infant
standard simulated data pain scores were compared with
the mean (across assessors) PainChek adaptive and
PainChek standard scores controlling for video segment,
no significant difference was detected between methods
(Wald χ²=1·3 p=0·51).
We examined the responsiveness of the scales using
painful and non-painful change scores with LMM results
described in table 2. All three PainChek Infant methods
reported a clinically significant change (a change in score
of more than 2 points) for the painful procedures,
with the LMM confirming a significant effect for the

responsiveness to a painful procedure of 4·4 (95% BCa CI
4·0–4·7) using the PainChek Infant adaptive and the
PainChek Infant standard methods, and 4·6 (95% BCa CI
3·7–5·6) using the PainChek Infant standard simulated
method. Similarly, the NFCS-R and ObsVAS methods
also reported clinically significant (>33% change) and
statistically significant responsiveness (table 2; figure 1).
Responsiveness proportions for each method at baseline
or preparation indicated a low frequency of infants with
high pain or distress levels: PainChek Infant adaptive
recognised nine (4%) of 231 infants having high baseline
pain or distress levels, PainChek Infant standard
recognised 13 (6%) of 238, NFCS-R single recognised
18 (8%) of 240 in the first testing session and 14 (6%) of
240 in the second, NFCS-R multiple recognised 18 (8%)
of 238 in the first testing session and 18 (8%) of 240 in
the second, ObsVAS recognised five (2%)of 236 in the
first testing session and five (2%) of 239 in the second,
and PainChek Infant standard simulation recognised
six (8%) of 80. LMM did not detect a significant difference
in the change in pain scores between those infants
reporting low pre-vaccination pain or distress compared
with those reporting high pre-vaccination pain or distress
(F=1·6; p=0·211).
Repeated measures correlation reported significant
correlations between PainChek Infant adaptive and the
following methods: ObsVAS (r=0·88, 95% CI 0·85–0·90;
p<0·0001), NFCS-R single (r=0·83, 95% CI 0·79–0·86;
p<0·0001), and NFCS-R multiple (r=0·82, 95% CI
0·78–0·85; p<0·0001); and between PainChek Infant
standard and these methods: ObsVAS (r=0·88, 95% CI
0·86–0·90; p<0·0001), NFCS-R single (r=0·82, 95% CI
0·79–0·85; p<0·0001), and NFCS-R multiple (r=0·83,
95% CI 0·79–0·85; p<0·0001; appendix p 4). Repeated

Painful event
Mean

SD

Non-painful event
95% BCa CI

Median

IQR

Mean

SD

Linear mixed model*
95% BCa CI

Median

IQR

β estimate†

95% BCa CI

p value

First testing session
ObsVAS

80·3

27·8

74·4 to 85·1

70 to 100

6·0

18·7

3·1 to 9·5

0·0

0 to 10

74·3

69·2 to 79·4

0·0010

NFCS-R multiple‡

83·0%

25·5%

78·1 to 87·4%

100·0%

93·5

75 to 100%

9·7%

31·0%

4·7 to 15·7%

0·0%

0 to 20%

73·4%

66·7 to 80·9%

0·0010

NFCS-R single‡

81·4%

28·4%

75·9 to 86·0% 100·0%

75 to 100%

6·4%

29·9%

1·5 to 11·1%

0·0%

0 to 5%

75·0%

68·8 to 82·0%

0·0010

PainChek Infant
adaptive§

4·6

1·8

4·2 to 4·9

5·0

4 to 6

0·2

1·1

0·0 to 0·4

0·0

0 to 1

4·4

4·0 to 4·7

0·0010

PainChek Infant
standard§

4·6

1·8

4·2 to 4·9

5·0

4 to 6

0·2

1·1

0·0 to 0·3

0·0

0 to 0

4·4

4·0 to 4·7

0·0010

ObsVAS

78·3

29·1

73·2 to 83·3

94·0

60 to 100

3·9

17·4

1·0 to 6·9

0·0

0 to 5

74·4

68·7 to 79·8

<0·0001

NFCS-R multiple‡

82·3%

25·9%

77·9 to 86·6% 100·0%

60 to 100%

5·9%

29·1%

0·9 to 10·5%

0·0%

0 to 0%

76·4%

70·0 to 83·3%

<0·0001

NFCS-R single‡

80·7%

28·5%

75·4 to 85·3%

60 to 100%

5·7%

28·0%

1·4 to 10·8%

0·0%

0 to 0%

75·0%

68·3 to 82·2%

<0·0001

4·8

1·7

5 to 6

0·2

0·0

0 to 1

Second testing session

PainChek Infant
standard simulated§

4·2 to 5·5

100·0%
6·0

1·4

–0·2 to 0·8

4·6

3·7 to 5·6

0·0020

BCa CI=bias corrected and accelerated confidence intervals. IQR=interquartile range. NFCS-R=Neonatal Facial Coding System-Revised. ObsVAS=Observer administered Visual Analogue Scale. *Linear mixed
model includes random effect for infant and fixed effect for assessor with bootstrap estimates. †Compared with non-painful procedure in which parameter is set to 0. ‡Scores ranged from 0 to 5 and change in
scores are presented here as percentages. §Scores range from 0 to 6. Scores were calculated using only valid datapoints (ie, missing datapoints were ignored), however; if all facial features were not visible then
the pain score was considered missing.

Table 2: Change in pain scores between painful and non-painful events for each assessment method
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PainChek Infant standard and ObsVAS

PainChek Infant adaptive and ObsVAS

3

+1·96 SD
2·7

Difference in Z scores

2
1
Mean
0·0

0
–1
–2

–1·96 SD
–2·6

–3
PainChek Infant standard and NFCS-R single

PainChek Infant adaptive and NFCS-R single

3

+1·96 SD
2·6

Difference in Z scores

2
1
Mean
0·0

0
–1
–2

–1·96 SD
–2·6

–3
PainChek Infant standard and NFCS-R multiple

PainChek Infant adaptive and NFCS-R multiple

3

+1·96 SD
2·6

Difference in Z scores

2
1
Mean
0·0

0
–1
–2
–3
–1·0

–1·96 SD
–2·6
–0·5

0

0·5

1·0

Mean Z scores

1·5

–1·0

–0·5

0

0·5

1·0

1·5

Mean Z scores

Figure 2: Repeated measures Bland-Altman plots for both testing sessions
The dashed lines represent the upper and lower limits of agreement, and the error bars the 95% CIs around the limits of agreement.

measures Bland-Altman plots for both testing sessions
found no systematic differences between the compared
measures (figure 2). For each comparison a mean
difference of 0·02 was reported (except the comparison
between NFCS-R multiple and PainChek Infant adaptive,
which had a mean difference 0·01), all within the
±1·96 limits of agreement indicating agreement between
methods (appendix p 5).
ICC results generally indicated moderate to excellent
agreement across all assessors for each method and
segment (table 3). Inter-rater reliability was typically better
e630

during the vaccination and recovery segments, ranging
from moderate (NFCS-R multiple at second testing had
an ICC 95% CI lower bound of 0·51), to excellent (ObsVAS
and PainChek Infant adaptive at first testing had an ICC
95% CI upper bound of 0·99). Inter-rater reliability in
assessing baseline and preparation segments ranged from
poor (NFCS-R single at second use had an ICC 95% CI
lower bound of 0·08) to excellent (ObsVAS at first use had
an ICC 95% CI upper bound of 0·96). PainChek Infant
adaptive and PainChek Infant standard consistently
reported moderate to excellent (≥0·81) inter-rater
www.thelancet.com/digital-health Vol 3 October 2021
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First testing session
Baseline

Second testing session

Preparation

During

Recovery

Baseline

Preparation

During

Recovery
0·96

ObsVAS
ICC

0·91

0·64

0·97

0·97

0·73

0·62

0·94

ICC 95%CI

0·81–0·96

0·30–0·84

0·94–0·99

0·93–0·99

0·48–0·88

0·29–0·83

0·88–0·97

p value

<0·0001

α

0·0001

<0·0001

<0·0001

<0·0001

0·0008

0·93–0·99

<0·0001

<0·0001

0·91

0·72

0·98

0·97

0·74

0·66

0·94

0·97

ICC

0·80

0·83

0·91

0·96

0·58

0·76

0·75

0·94

ICC 95% CI

0·59–0·91

0·62–0·93

0·82–0·96

0·92–0·98

0·22–0·81

0·51–0·90

0·51–0·89

NFCS-R multiple

p value

<0·0001

<0·0001

<0·0001

0·82

0·87

0·91

0·97

ICC

0·67

0·58

0·93

ICC 95% CI

0·38–0·85

0·21–0·81

0·85–0·97

p-value

0·0001

0·0019

α

0·73

0·63

ICC

0·81

0·83

0·97

0·92

NA

NA

NA

NA

ICC 95% CI

0·61–0·92

0·65–0·93

0·93–0·99

0·83–0·97

NA

NA

NA

NA

α

0·0004

0·85–0·98

<0·0001

<0·0001

<0·0001

<0·0001

0·69

0·82

0·78

0·96

0·93

0·48

0·66

0·89

0·93

0·85–0·97

0·08–0·75

0·35–0·85

0·79–0·95

0·0057

0·0003

0·58

0·69

NFCS-R single

<0·0001

<0·0001

0·93

0·95

0·85–0·97

<0·0001

<0·0001

0·90

0·95

PainChek Infant adaptive

p value

<0·0001

<0·0001

<0·0001

<0·0001

NA

NA

NA

NA

0·82

0·85

0·97

0·92

NA

NA

NA

NA

ICC

0·87

0·83

0·97

0·94

NA

NA

NA

NA

ICC 95% CI

0·72–0·95

0·66–0·93

0·93–0·99

0·88–0·98

NA

NA

NA

NA

α
PainChek Infant standard

p value
α

<0·0001

<0·0001

<0·0001

<0·0001

NA

NA

NA

NA

0·90

0·84

0·97

0·95

NA

NA

NA

NA

α=Cronbach alpha. ICC=intraclass correlation coefficient. NFCS-R=Neonatal Facial Coding System-Revised. ObsVAS=Observer administered Visual Analogue Scale.

Table 3: Inter-rater reliability and internal consistency outcomes for each pain and distress method of assessment at each segment for both testing sessions

ObsVAS

NFCS-R multiple

NFCS-R single

PainChek Infant

ICC

ICC 95% CI

p value

α

ICC

ICC 95% CI p value

α

ICC

ICC 95% CI

p value

α

ICC

ICC 95% CI

p value

Overall

0·98

0·98–0·99

<0·0001

0·98

0·97

0·96–0·97

<0·0001

0·97

0·96

0·96–0·97

<0·0001

0·96

0·99

0·98–0·99

<0·0001

α
0·99

Baseline

0·85

0·79–0·90

<0·0001

0·86

0·81

0·73–0·87

<0·0001

0·82

0·81

0·73–0·87

<0·0001

0·81

0·93

0·88–0·96

<0·0001

0·93

Preparation

0·95

0·93–0·97

<0·0001

0·95

0·90

0·85–0·93

<0·0001

0·90

0·86

0·80–0·90

<0·0001

0·86

0·84

0·72–0·91

<0·0001

0·84

During

0·94

0·91–0·96

<0·0001

0·94

0·87

0·81–0·91

<0·0001

0·87

0·94

0·92–0·96

<0·0001

0·94

0·98

0·97–0·99

<0·0001

0·98

Recovery

0·95

0·93–0·97

<0·0001

0·95

0·95

0·93–0·97

<0·0001

0·95

0·94

0·91–0·96

<0·0001

0·94

0·97

0·94–0·98

<0·0001

0·97

Intra-rater reliability was based on repeat measures from the first and second testing session for ObsVAS and NFCS-R, whereas intra-rater reliability for PainChek Infant was based on repeat measures from
Painchek Infant adaptive (first testing session), Painchek Infant standard (first testing session), and Painchek Infant standard simulated (second testing session). α=Cronbach alpha. ICC=intraclass correlation
coefficient. NFCS-R=Neonatal Facial Coding System-Revised. ObsVAS=Observer administered Visual Analogue Scale.

Table 4: Intra-rater reliability and internal consistency outcomes for each pain and distress method of assessment at each segment

agreement across all segments for the first session.
Internal consistency between assessors (table 3) was
acceptable for all methods and segments except for first
testing when assessing the preparation segment for
NFCS-R single (α=0·63); second testing when assessing
baseline segment NFCS-R single (α=0·58) and NFCS-R
multiple (α=0·69), and when assessing preparation
segment for ObsVAS (α=0·66). PainChek Infant adaptive
and PainChek Infant standard methods reported high
values of internal consistency ranging from α=0·82 when
www.thelancet.com/digital-health Vol 3 October 2021

assessing the baseline segment with PainChek Infant
adaptive, to α=0·97 when assessing the during vaccination
segment with PainChek Infant standard.
Intra-rater reliability between the first and second
testing sessions overall and separated for each video
segment was excellent for ObsVAS, NFCS-R multiple,
and NFCS-R single (table 4). Comparison of the three
PainChek Infant methods reported good-to-excellent
intra-rater reliability both overall and separated for each
video segment (table 4).
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Discussion
This study evaluated the psychometric properties of
PainChek Infant compared with the NFCS-R and
ObsVAS, to determine its suitability of use in the
assessment of procedural pain in infants. Both com
parator tools rely on the user to observe and use their
judgement related to the presence of pain or the intensity
of the pain or distress being displayed, which could have
an effect on how pain is treated. These user-reliance
properties are common in other existing observational
pain assessment tools. In comparison, PainChek Infant,
resulting from advances in AI, uses automated facial
expression analysis to automatically decode the face and
determine the presence of six pain-related facial
expressions. PainChek Infant analysis is completed
without user subjectivity and in real time, in 3 s.
Additionally, PainChek Infant is operated from a mobile
device, therefore offering potential benefits in relation to
workflow, documentation, and communication. Using
these properties together, PainChek Infant presents an
opportunity to improve pain assessment in infants, and
could lead to changes in clinical practice that help to
address the current challenges around making pain
visible in the infant population group.5 When compared
with NFCS-R, PainChek Infant shows similar frequencies
of recognition of facial actions common to the two scales,
supporting the similarity of their construct. Furthermore,
changes in total pain scores across the four video
segments for PainChek (adaptive and standard), NFCS-R
(single and multiple), and ObsVAS followed the same
patterns (figure 1), in line with what would be anticipated
for infants undergoing immunisation.
Differentiating pain from distress using currently
available observational pain scales is difficult.25,26 Here,
we acknowledge the potential for overlap between
pain and non-pain related distress on infants’ facial
expressions. Nonetheless, our findings are encouraging
considering a clear change in facial expressions
pre-needle and post-needle insertion, starting from the
baseline through to the recovery. Our findings confirm
the responsiveness of all three scales to pain intervention,
as evidenced by clinically and statistically significant
effect of the painful procedure. This significance is
support by a study from 2012, in which facial expressions
similar to those covered by PainChek Infant and NFCS-R
were analysed in infants aged 2, 4, 6, and 12 months, for
up to a minute post-needle insertion. The study showed
that the expressions were associated with pain or painrelated distress, rather than other emotions such as
sadness or anger.27 Interestingly, AU25 (parting lips), as
detected using PainChek Infant, and horizontal mouth
opening as defined by NFCS-R, were the most common
features detected in both pre-vaccination segments (ie, at
baseline and preparation). These two segments occur
before the painful stimuli (ie, the injection), and so it
would be reasonable to assume that AU25 is not
representative of pain-related distress. This finding could
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assist users in differentiating non-pain related facial
expressions (neutral, positive, or negative) from those of
pain, especially when no source of potential pain is
suspected. However, AU25 has been shown to be a
prominent feature of pain-related distress in infants
undergoing immunisation across a range of ages,
occurring together with AU3 or AU4 (brow lowered or
pulled together), AU6 or AU7 (cheek raised or lower
eyelid tightening), AU9, AU10, or AU11 (lip raise or
nasolabial furrow), AU20, AU25, and AU26c, or AU27
(widely open cry mouth), and AU43 (eyes closed).28 AU4,
AU9, AU20, AU25, and AU43 are included in PainChek
Infant together with AU15 (lip corner depressor), which
was shown to be prominent during pain in the original
20 facial actions used to code the images and used to
develop the PainChek Infant algorithms. A 2011 study
also reported AU15’s association with pain, as adjudged
by the NFCS.29 NFCS-R recognised facial actions also
show concordance with these facial actions, specifically
AU4, AU9, AU20, AU25, and AU43. Hence, both tools
have clinical utility in verifying and quantifying pain
when a source of pain is known or suspected.
PainChek Infant showed excellent convergent validity;
results of PainChek Infant aligned with both NFCS-R
and ObsVAS. PainChek Infant also exhibited moderate
to excellent inter-rater reliability across all four video
segments. Furthermore, its inter-rater reliability was
comparable to, or better than, the comparator scales:
NFCS-R and ObsVAS. Strong inter-rater reliability was
particularly evident for assessments done at baseline
and during the preparation phase. The internal
consistency of the two modes of PainChek Infant
assessment were also shown to be more than acceptable,
with high α values. The internal consistency for NFCS-R
after multiple viewings of the video segment were also
high and comparable with that reported for the Modified
Behavioural Pain Scale.26 The inter-rater reliability of the
three tools used was excellent (with overall ICC values
being ≥0·96), as were the α scores.
Despite the strategies used to mitigate against various
methodological limitations, some limitations remained.
For one, there are challenges associated with evaluating
the psychometric properties of scales in which a gold
standard does not exist. Assessment is therefore
dependent on the results from a range of indirect
measures of validity, all of which have limitations. It is
not possible to blind the assessors to the circumstances
surrounding the infant, therefore potentially biasing
assessors’ scale application. To help overcome this
potential bias, four assessors (of clinical and non-clinical
background) were used and, additionally, the EDMS
employed in the study automatically muted all videos to
ensure that sound did not affect the assessors’ scores.
Assessors were also broadly aware of the purpose of the
study, and although specific details and hypotheses were
not revealed, this could have influenced their application
of the scales. Also, establishing the validity of one
www.thelancet.com/digital-health Vol 3 October 2021
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measure on the basis of correlation with another
might rely on circular logic, hence the use of multiple
assessment methods to establish scale validity. To
further establish the validity of our findings, we used
PainChek Infant in both standard and adaptive modes,
therefore conducting assessments using a fixed video
duration and a minimum number of valid images, and
we also used NFCS-R in single view and multiple
viewing scenarios.
With respect to examining the responsiveness of the
assessments, we found a very low frequency of high pain
or distress levels at baseline or preparation at both testing
sessions, and the data were insufficient for statistical
examination. Although data were pooled to allow respon
siveness to be examined, the relatively low sample,
combined with a non-significant result, suggests that
responsiveness should be further examined with a larger
sample to confirm responsiveness of the scale. Future
work is also required to evaluate the specificity of the
tool, and differences in facial expressions in response to
similarly intense painful and non-painful distress stimuli
should be compared; this was beyond the scope of the
current study.
This study is also limited by the fact that assessors did
not face the infants directly, but did their assessments
by viewing video recordings. Although this method of
assessing pain differs from clinical practice, the use of
video recordings to validate pain assessment has been
successfully done before.8,9,25,26 Also, video recording
allows multiple viewings of the segments (such as in
the case of NFCS-R and ObsVAS), which has been
considered a strength.27 Furthermore, we showed that by
using the PainChek Infant simulator, the results
obtained by pointing the device at the computer screen
were comparable to those obtained by presenting the
videos directly to the software development kit (ie, real
world processing). Several failures were recorded with
the simulator system; however, considering that in real
world use the assessor decides on the best time to
initiate assessment (eg, at a time when the infant’s face
is not obstructed) these failures would likely not occur
in the real world. Every effort has been made to
minimise the risk of failure of the automated facial
analysis through innovative design, inbuilt alerts, and
user training; however, it is acknowledged that failure
still might occur, and, dependent on the results of trials
in clinical practice, a manual assessment option might
need to be added.
The algorithms incorporated in PainChek Infant have
been trained and validated using images of infants aged
1–12 months. As such, use of the tool on younger or older
children is yet to be tested. Furthermore, the infants
included in the evaluation were all White, and this must
be considered when using it with infants of other races.
However, it should be noted that much has been
written about the universality of facial expressions, and
existence of common pain expressions.30 Additionally,
www.thelancet.com/digital-health Vol 3 October 2021

we acknowledge that facial expressions in some infants
might be absent due to conditions associated with facial
palsy. In these cases, multidimensional scales would be
preferred.
In this study we showed that PainChek Infant has goodto-excellent validity, reliability, and internal consistency
when compared with the NFCS-R and the ObsVAS. In
taking only 3 s to complete, removing observer bias
associated with high exposure to facial expressions of
pain29 and automating pain assessment, we believe
PainChek Infant represents a meaningful advance in the
assessment and monitoring of procedural pain in infants.
Still, further research is required to evaluate its clinical
utility in clinical practice.
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